Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05053880
Title A Study to Evaluate Safety and Efficacy of ACT001 and Anti-PD-1 in Patients With Surgically Accessible Recurrent Glioblastoma Multiforme
Recruitment Unknown status
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Accendatech USA Inc.
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.